Management for multiple endocrine neoplasia 1 during pregnancy: clinical and genetic analysis for a pedigree and review of literature

Objective To investigate the clinical characteristics and management strategies for multiple endocrine neoplasia 1 (MEN1) during pregnancy. Methods The gender, age, detailed medical history, clinical symptoms and signs, laboratory, imaging and pathological examination data of a MEN1 proband were col...

Full description

Bibliographic Details
Main Author: Ye Zhiwei, Deng Hongrong, Liu Zhigu, Lin Huimin, Xu Wen, Yao Bin
Format: Article
Language:zho
Published: Editorial Office of Journal of New Medicine 2022-03-01
Series:Xin yixue
Subjects:
Online Access:https://www.xinyixue.cn/fileup/0253-9802/PDF/1648889568193-1511339874.pdf
_version_ 1797987377715609600
author Ye Zhiwei, Deng Hongrong, Liu Zhigu, Lin Huimin, Xu Wen, Yao Bin
author_facet Ye Zhiwei, Deng Hongrong, Liu Zhigu, Lin Huimin, Xu Wen, Yao Bin
author_sort Ye Zhiwei, Deng Hongrong, Liu Zhigu, Lin Huimin, Xu Wen, Yao Bin
collection DOAJ
description Objective To investigate the clinical characteristics and management strategies for multiple endocrine neoplasia 1 (MEN1) during pregnancy. Methods The gender, age, detailed medical history, clinical symptoms and signs, laboratory, imaging and pathological examination data of a MEN1 proband were collected. And the demographic characteristics, clinical characteristics and auxiliary examination of 20 members from the MEN1 family were also collected. MEN1 cases during pregancy were searched from PubMed and Wanfang Data using the keywords of “Multiple Endocrine Neoplasia Type 1“and“Pregnant” in both English and Chinese. Results The main clinical manifestations of the MEN1 proband were pituitary microadenoma (galactorrhea, elevated prolactin), pancreatic endocrine tumor (hypoglycemia) and parathyroid adenoma (asymptomatic, elevated parathyroid hormone and blood calcium). Gene analysis confirmed that exon 9 of MEN1 gene (CGA > TGA, Arg415Term) was the pathogenic mutated gene. The father and daughter of the proband carried this pathogenic mutation and had hyperparathyroidism. After drug treatment for pituitary microadenoma and surgical treatment for pancreatic endocrine tumor and parathyroid adenoma, the proband was pregnant and delivered a female infant successfully. During this period, there was no recurrence of galactorrhea and hypoglycemia, the levels of parathyroid hormone and blood calcium were stable, and fetal growth and development were normal. A total of seven pregnant cases of MEN1 in English literature and one in Chinese literature were retrieved. It was found that all MEN1 patients developed onset of diseases at childbearing age. As for clinical symptoms, parathyroid, pancreas and pituitary were the most involved. Most patients had family history and MEN1 gene mutation. In terms of pregnancy outcome, seven patients delivered successfully under strict condition monitoring and treatment. Conclusion Clinicians’ active detection, diagnosis and treatment will help to improve the prognosis of MEN1 patients and their offspring.
first_indexed 2024-04-11T07:47:46Z
format Article
id doaj.art-ec876aa96c304268a2b5db9830ae6763
institution Directory Open Access Journal
issn 0253-9802
language zho
last_indexed 2024-04-11T07:47:46Z
publishDate 2022-03-01
publisher Editorial Office of Journal of New Medicine
record_format Article
series Xin yixue
spelling doaj.art-ec876aa96c304268a2b5db9830ae67632022-12-22T04:36:14ZzhoEditorial Office of Journal of New MedicineXin yixue0253-98022022-03-0153321422010.3969/j.issn.0253-9802.2022.03.013Management for multiple endocrine neoplasia 1 during pregnancy: clinical and genetic analysis for a pedigree and review of literatureYe Zhiwei, Deng Hongrong, Liu Zhigu, Lin Huimin, Xu Wen, Yao Bin0△Department of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, ChinaObjective To investigate the clinical characteristics and management strategies for multiple endocrine neoplasia 1 (MEN1) during pregnancy. Methods The gender, age, detailed medical history, clinical symptoms and signs, laboratory, imaging and pathological examination data of a MEN1 proband were collected. And the demographic characteristics, clinical characteristics and auxiliary examination of 20 members from the MEN1 family were also collected. MEN1 cases during pregancy were searched from PubMed and Wanfang Data using the keywords of “Multiple Endocrine Neoplasia Type 1“and“Pregnant” in both English and Chinese. Results The main clinical manifestations of the MEN1 proband were pituitary microadenoma (galactorrhea, elevated prolactin), pancreatic endocrine tumor (hypoglycemia) and parathyroid adenoma (asymptomatic, elevated parathyroid hormone and blood calcium). Gene analysis confirmed that exon 9 of MEN1 gene (CGA > TGA, Arg415Term) was the pathogenic mutated gene. The father and daughter of the proband carried this pathogenic mutation and had hyperparathyroidism. After drug treatment for pituitary microadenoma and surgical treatment for pancreatic endocrine tumor and parathyroid adenoma, the proband was pregnant and delivered a female infant successfully. During this period, there was no recurrence of galactorrhea and hypoglycemia, the levels of parathyroid hormone and blood calcium were stable, and fetal growth and development were normal. A total of seven pregnant cases of MEN1 in English literature and one in Chinese literature were retrieved. It was found that all MEN1 patients developed onset of diseases at childbearing age. As for clinical symptoms, parathyroid, pancreas and pituitary were the most involved. Most patients had family history and MEN1 gene mutation. In terms of pregnancy outcome, seven patients delivered successfully under strict condition monitoring and treatment. Conclusion Clinicians’ active detection, diagnosis and treatment will help to improve the prognosis of MEN1 patients and their offspring.https://www.xinyixue.cn/fileup/0253-9802/PDF/1648889568193-1511339874.pdf|multiple endocrine neoplasia 1|men1 gene|pregnancy|autosome|pituitary adenoma
spellingShingle Ye Zhiwei, Deng Hongrong, Liu Zhigu, Lin Huimin, Xu Wen, Yao Bin
Management for multiple endocrine neoplasia 1 during pregnancy: clinical and genetic analysis for a pedigree and review of literature
Xin yixue
|multiple endocrine neoplasia 1|men1 gene|pregnancy|autosome|pituitary adenoma
title Management for multiple endocrine neoplasia 1 during pregnancy: clinical and genetic analysis for a pedigree and review of literature
title_full Management for multiple endocrine neoplasia 1 during pregnancy: clinical and genetic analysis for a pedigree and review of literature
title_fullStr Management for multiple endocrine neoplasia 1 during pregnancy: clinical and genetic analysis for a pedigree and review of literature
title_full_unstemmed Management for multiple endocrine neoplasia 1 during pregnancy: clinical and genetic analysis for a pedigree and review of literature
title_short Management for multiple endocrine neoplasia 1 during pregnancy: clinical and genetic analysis for a pedigree and review of literature
title_sort management for multiple endocrine neoplasia 1 during pregnancy clinical and genetic analysis for a pedigree and review of literature
topic |multiple endocrine neoplasia 1|men1 gene|pregnancy|autosome|pituitary adenoma
url https://www.xinyixue.cn/fileup/0253-9802/PDF/1648889568193-1511339874.pdf
work_keys_str_mv AT yezhiweidenghongrongliuzhigulinhuiminxuwenyaobin managementformultipleendocrineneoplasia1duringpregnancyclinicalandgeneticanalysisforapedigreeandreviewofliterature